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J. Heckenkamp,* M. Aleksic, M. Gawenda, S. Breuer, J. Brabender, A. Mahdavi,
F. Aydin and J.S. BrunkwallDivision of Vascular Surgery, University of Cologne, Koeln, GermanyObjectives. Photodynamic therapy (PDT) is a promising strategy to limit restenosis. PDT depletes the resident cells from
the vessel wall without adventitial cell ingrowth. This study was undertaken to further explore the mechanisms by which
PDT of matrix acts on key mechanisms in the development of restenosis.
Materials andMethods. Control and PDT-treated collagen type-I matrix gels were prepared. Thereafter, untreated human
fibroblasts were seeded on matrix gels (nZ12). Fibroblast proliferation and invasive migration were quantified by calibrated
phase contrast microscopy. Fibroblast bFGF and TGF-b1 mRNA expression were analyzed using a quantitative real-time
reverse transcription polymerase chain reaction.
Results. Fibroblast proliferation on PDT-treated matrix gels was reduced by 30 and 76% after 3 and 7 days, respectively (3
days: P%0.01, 7 days: P%0.001). PDTof matrix gels led to a 47% reduction of migration after 3 days and 51% after 7 days
(P%0.001). PDT led to a 77% reduction of fibroblast TGF-b1 mRNA (P%0.02) and to a 79% reduction of bFGF mRNA
(P%0.03).
Conclusions. PDT of matrix-induced reduction of bFGF and TGF-b1 mRNA levels may be important mechanisms of
reducing fibroblast proliferation and invasive migration and thus the development of restenosis. These newly identified
mechansisms highlight PDT’s pleiotropic effects on the vessel wall and its potential clinical value.Introduction
The development of procedures to treat arterial
occlusive disease represents a very important achieve-
ment in the field of surgery. Both vascular surgical and
interventional procedures are used successfully. How-
ever, restenosis still remains the major obstacle to
satisfactory long term patency after therapeutic inter-
ventions for the treatment of arterial disease. Vascular
restenosis is a post-interventional multifactorial pro-
cess involving the migration of adventitial cells into
the subintimal space, their proliferation and depo-
sition of extracellular matrix proteins.1–3 Although the
molecular basis of vascular post-interventional rest-
enosis is not yet fully understood, it has been shown,
that the development of restenotic lesions involves the
production and release of cytokines and growth
factors, which alter cell functions and cell-matrix
interactions and therefore promote the developmenting author. Joerg Heckenkamp, MD, Division of
gery, University of Cologne, Joseph–Stelzmann-Str. 9,
n, Germany.
: j_heckenkamp@hotmail.com (J. Heckenkamp).
0651+ 09 $35.00/0 q 2004 Elsevier Ltd. All rights reserof restenosis.4 Two growth factors playing crucial roles
in the development of restenosis are transforming
growth factor-b1 (TGF-b1) and basic fibroblast growth
factor (bFGF).5–7 Since, restenosis remains the major
drawback to vascular interventions, therapeutic mod-
alities aimed at preventing its development continue
to receive much attention.
Among numerousmechanical and pharmacological
approaches, several current investigations, such as
gene-therapy, ionizing irradiation, and drug eluting
stents have been investigated to inhibit the occurrence
of restenosis. However, these options are still under-
going clinical trials and may not be applicable widely.
Photodynamic therapy (PDT) is an alternative
effective experimental and new clinical approach to
favourably modulate the vascular healing response.
Early clinical trials for atherosclerotic plaque
reduction and post-interventional femoropopliteal
restenosis have demonstrated the feasibility of vascu-
lar PDT in humans.8,9 PDT is a technique in which
visible, wavelength-specific light is applied to activate
otherwise inert photosensitizer dyes to produce local
free-radical moieties, without the generation of heat.10
With the absorption of light, the produced reactiveEur J Vasc Endovasc Surg 28, 651–659 (2004)
doi:10.1016/j.ejvs.2004.08.013, available online at http://www.sciencedirect.com onved.
J. Heckenkamp et al.652species exert their effects by damaging cells,11 and by
affecting extracellular matrix molecules.12 These
effects of PDT on blood vessels result in eradication
of the cells in the vascular wall without causing
thrombosis or inflammation, and no structural deterio-
ration of the remaining blood vessel extracellular
matrix wall has been noted.13 However, the modu-
lation of adjacent adventitial and periadventitial cell
populations by PDT of extracellular vascular matrix
and therefore the mechanisms in the long-term ability
of PDT to inhibit intimal hyperplasia are still unclear.
This study was designed to get further insights into
the molecular aspects of PDT-induced changes in
adventitial vascular cell function using a clinically
available photosensitizer and therefore to develop an
approach for inhibiting clinical restenosis in the future.
We examined whether PDT of matrix influences the
proliferation and invasive migration of untreated
adventitial cells and focusing on the expression of
key growth factors bFGF and TGF-b1.Materials and MethodsCell culture
Primary human saphenous vein was obtained fresh
from the operation room and adventitial fibroblasts
were cultured and characterized as described pre-
viously.14,15 Fibroblasts were cultured in a humidified
37 8C incubator (5% CO2) and the medium (Media 199
(Life Technologies, Gaithersburg, MD, USA) sup-
plemented with 10% fetal bovine serum (FBS),
100 U/ml penicillin, 100 mg/ml streptomycin, and
0.6 mol/l L-Glutamine (Gibco, Grand Island, NY,
USA)) was replaced every 48 h. Upon reaching
confluence, cells were split 1:4 and cells at passage
two through five were used for experiments.Preparation of three-dimensional (3D) collagen gels
The 3D collagen matrices were constructed in 12-well
cell culture plates (Falcon, Becton Dickinson, Lincoln
Park, NY, USA) as described before in detail.12 In brief,
Vitrogen 100 (Collagen Biomaterials, Palo Alto, CA,
USA), a solution of pepsin-solubilized bovine 95–98%
type I collagen and collagen type III (1.5 mg/ml
collagen) was mixed with cell culture media. Gelling
was initiated by warming the solution to 37 8C in an
incubator overnight. In PDT groups 2 mg/ml of the
photosensitizer drug methylene blue (MB: CIBA-
Geigy, Basel, Switzerland) was added and the gels
were protected from ambient light.Eur J Vasc Endovasc Surg Vol 28, December 2004PDT treatment of collagen gels
The 3D collagen matrix gels were irradiated with
thermoneutral laser light dosimetry (100 J/cm2;
100 mW/cm2; lZ660 nm) delivered by a diode laser
(B and W Tek Inc., Newark, DE, USA) coupled to a
1 mm silica core fiber fitted with a microlens to
provide a uniform spot as described previously.12
The untreated human fibroblasts were seeded on the
gels 1 h after PDT. Negative controls were untreated
matrix gels and gels treated with laser only or
photosensitizer only.Proliferation and invasive cell migration assay
Fibroblasts were seeded on the 3Dmatrix gel surface at
a density of 8!104 cells/well. Three independent
experiments were performed. The cell culture medium
was changed every 48 h. Invasive migration into the
gel was quantified at 3 and 7 days after seeding by
calibrated phase contrast microscopy (Zeiss IM35,
Germany) using !200 magnification.15 To assess the
number of fibroblasts undergoing invasive migration,
cells were counted in four random fields per well on
the surface and four random fields in a cylindrical field
through the entire depth of the matrix gels in a blinded
fashion for every experiment. To quantify cell pro-
liferation, the total number of cells was obtained by the
sum, per microscopic field, of cells on the surface and
cells migrated into the gel. To prevent photosensitizer
absorption of light in PDT groups, gels were inspected
using a 500–540 nm2 bandpass filter in the dark. These
wavelengths are not absorbed by the photosensitizer
MB. To correct the migration data for fibroblast
proliferation the number of migrating cells was
normalized to the number of cells on the surface as
detailed previously.15Real time-RT–PCR reaction of TGF-b1 and b-FGF mRNA
RNA extraction and cDNA synthesis
Total fibroblast RNA was isolated by a guanidinium
isothiocyanate method at 6, 12, and 24 h after seeding
by using the Qiagen RNeasye Mini-Kit according to
the manufacturer’s instructions. Three independent
experiments were performed. No significant
migration was noted at these early time points.
cDNAs were prepared using the Clontech first-
strande cDNA Synthesis Kit according the manufac-
turers’ instructions.
PCR quantification of mRNA expression
Quantitation of TGF-b1/ b-FGF cDNA and an internal
Modulation of Cell Functions by PDT of Matrix 653reference cDNA (b-actin) was performed using a
fluorescence detection method (ABI PRISM 7700
Sequence Detection System, (TaqMane) Perkin
Elmer (PE) Applied Biosystems, Foster City, CA,
USA), as described previously.16–18
The PCR reaction mixture consisted of 600 nM of
each primer, 200 nM probe, 5 U AmpliTaq Gold
Polymerase, 200 mM each dATP, dCTP, dGTP, 400 mM
dUTP, 5.5 mM MgCl2, and 10 ml TaqMane Universal
Master Mix, Applied Biosystems, Foster City, CA,
USA). Cycling conditions were 50 8C for 10 s, 95 8C for
10 min, followed by 46 cycles at 95 8C for 15 s and
60 8C for 1 min. The primers and probes used are listed
in Table 1.A
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AStatistical analysis
Results are expressed as median and range. For
comparisons between multiple groups, the Kruskall–
Wallis tests were used.
Taqmane analyses yield values that are
expressed as ratios between two absolute measure-
ments (gene of interest/internal reference gene).
TGF-b1/b-FGF expression levels in human vascular
fibroblasts cultivated on PDT-treated gels and
controls were compared using the Mann–Whitney
test to identify significant differences in expression
levels.M
R
A
G
T
G
T
G
-3
0 TResultsd
p
ro
b
e
s
16
04
5
b
-a
ct
in
G
G
C
T
A
C
A
G
C
T
T
-3
0
G
T
C
A
C
G
C
A
C
G
A
T
T
T
-3
0
C
C
A
C
G
G
C
C
G
A
G
C
G
G
-3
0 T
A
M
R
A
T
G
A
A
C
C
C
G
T
G
T
T
G
-3
0
T
C
G
C
C
A
G
G
A
A
T
T
G
-3
0
C
A
C
G
T
G
G
A
G
C
T
G
T
A
C
C
A
G
A
A
A
T
A
C
A
G
C
-3
0 T
A
C
A
A
T
C
A
A
G
C
T
A
C
A
A
C
-3
0
G
C
C
A
G
G
T
A
A
C
G
G
T
T
A
-3
0
A
G
A
G
A
G
A
G
G
A
G
T
T
G
T
G
T
C
T
A
T
C
A
A
A
G
G
A
G
TPDT effects on fibroblast proliferation
PDT of the collagen gels decreased the overall cell
number per microscopic field by 30% after 3 days and
76% after 7 days (P%0.01 and P%0.001, respectively),
compared to controls (Fig. 1). The number of fibro-
blasts seeded on PDT-treated gels decreased signifi-
cantly from day 3 to day 7 (P%0.001), whereas the cells
on control gels showed proliferation. Negative con-
trols with photosensitizer only and light only showed
similar proliferation patterns compared to negative
controls without photosensitizer and light irradiation
(data not shown).T
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APDT effects on invasive fibroblast migration
PDTof the collagen gels decreased the total number of
cells migrating into the gels by 62% after 3 days and
88% after 7 days (P%0.01 and P%0.001, respectively,
Fig. 2(a) and (b)). However, due to the different cellEur J Vasc Endovasc Surg Vol 28, December 2004
Fig. 1. Total number offibroblasts seeded on control or PDT-treatedmatrix gels per microscopic field. Cells on the surface and
cells migrated into the gels were quantitated after 3 and 7 days. Data are expressed as median and range. * denotes P%0.01 in
controls as compared to PDT after 3 days and C denotes P%0.001 after 7 days. The number of fibroblasts seeded on PDT-
treated gels significantly decreased from day 3 to day 7 (# denotes P%0.001 PDT, after 3 days vs. after 7 days).
J. Heckenkamp et al.654numbers on the gel surface, the percentage of
fibroblasts that migrated into the 3D gels compared
to the cell number on the surface, was lower (47% at 3
days and 51% at 7 days, P%0.01 and P%0.001,
respectively, Fig. 3). Cells on control matrix gels
(laser only, photosensitizer only) had migration
patterns similar to untreated matrix gels (data not
shown).TGF-b1 and bFGF mRNA expression
TGF-b1 mRNA expression was detectable by quanti-
tative real-time PCR (TaqMan) in all samples. The
median TGF-b1 mRNA expression in relation to the
internal reference gene b-actin was not significantly
different after 6 and 12 h. After 24 h fibroblasts seeded
on PDT-treated gels expressed significantly less
TGF-b1 mRNA, compared to controls (77%, P%0.02,
Fig. 4).
bFGF mRNA expression was detectable by quanti-
tative real-time PCR (TaqMan) in all samples. The
median bFGF mRNA expression in relation to the
internal reference gene b-actin was also not signifi-
cantly different after 6 h. The difference between the
two groups after 12 h was not significant (P%0.06).
However, after 24 h fibroblasts seeded on PDT-treated
gels expressed significantly less bFGF mRNA com-
pared to controls (79%, P%0.03, Fig. 5).Eur J Vasc Endovasc Surg Vol 28, December 2004Discussion
The occurrence of restenosis after all forms of vascular
reconstruction, whether interventional or surgical, is
an unsolved problem. This in vitro study demonstrated
that PDT of collagen matrix using the clinically
available photosensitizer dye MB favourably modu-
lates untreated human fibroblast function possibly due
to a reduction of key growth factor mRNA expression.
Althoughmedial smooth muscle cells are important
in the development of restenosis, adventitial cells have
been implicated to also play a pivotal role in the
development of neointimal thickening. Therefore,
adventitial fibroblasts were used in this study.19,20
The utilization of venous adventitial fibroblasts is well
established and fibroblasts in culture are able to adapt
rapidly to in vitro conditions, regardless their venous
or arterial origin. Furthermore, because cellular func-
tion may be species-specific, human cells were used.
PDT inhibits intimal hyperplasia by causing acute
apoptotic cell death in the treated vascular wall
segment, which is followed by periadventitial cell
repopulation of the adventitia but not the media.13
Therefore, the cells themselves were not PDT-treated
in an effort to simulate this in vivo repopulation of the
PDT-treated cell-free vascular extracellular matrix
scaffold by untreated adjacent cell populations. MB
as a photosensitzer was used due to its favourable
properties for clinical PDT such as the maximum light
Fig. 2. (a, b) Total number of fibroblasts on the surface and migrating into control or PDT-treated collagen gels. Cells were
counted after (a) 3 and (b) 7 days. Data are expressed as median and range. * denotes P%0.001 migrated cells in controls as
compared to PDT after 7 days. Cell numbers on the surface were also significantly decreased by PDT at both time points (C
denotes P%0.01 controls vs. PDT after 3 days, # denotes P%0.001 controls vs. PDT after 7 days).
Modulation of Cell Functions by PDT of Matrix 655absorption at more than 650 nm, which allows
homogenous vascular wall penetration that is unaf-
fected by blood.21 In addition, it is clinically approved,
inexpensive, and can be administered topically.21
Since, 3D in vitro systems provide a close biological
model to study cell–matrix interactions a 3D collagen
matrix model was used in this study.22 Collagen type I
was chosen because it is one of the major connective
tissue components of the vascular wall, surrounding
vascular cells.23 Although this collagen matrix does
not fully reflect the composition of vascularextracellular matrix in vivo, it has been shown to be a
suitable model.15
PDT of collagen gels not only reduced fibroblast
proliferation but also resulted in a lower number of
cells at 7 days compared to 3 days. This implies that
cells detach from the collagen gel surface, possibly
because of structural alterations of matrix binding sites
after PDT.12 In addition, it has been shown that PDT,
using the experimental photosensitizer chloralumi-
num-sulfonated phthalocyanine (CASPc), inactivates
the functional activity of matrix-associated growthEur J Vasc Endovasc Surg Vol 28, December 2004
Fig. 3. Percentage of fibroblasts migrating into the gel as compared to the fibroblast numbers on the surface. Cells were
counted after 3 and 7 days. Data are expressed as median and range. * denotes P%0.001 in controls as compared to PDTafter 7
days. The percentage of migrated cells in controls and PDT-treated gels increased significantly from day 3 to day 7 (C
denotes P%0.001 in controls, # denotes P%0.01 in PDT).
J. Heckenkamp et al.656factors such as bFGF and TGF-b.24,25 These effects of
PDT might explain the reduction in cell proliferation.
However, the effects of PDT-treated matrix on the
proliferative response of fibroblasts on a molecular
level have not yet been elucidated.
After therapeutic catheter-based interventions or
vein bypass grafting smooth muscle cell,Fig. 4. Ratio between TGF-b1 mRNA expression and control b-a
treated matrix gels after 6, 12 and 24 h. Data are expressed as m
PDT after 24 h. mRNA expression after 6 and 12 h did not sho
Eur J Vasc Endovasc Surg Vol 28, December 2004myofibroblast, and fibroblast migration into the sub-
intimal space occurs as a consequence of mechanical
injury to the vessel wall and this migration plays a
critical role in the development and progression of
luminal renarrowing.26 The present study showed a
significant reduction of fibroblast migration into PDT-
treated matrix gels using the photosensitizer MB.ctin PCR products in fibroblasts seeded on control and PDT-
edian and range. * denotes P%0.02 in controls as compared to
w statistical differences.
Fig. 5. Ratio between bFGF mRNA expression and control b-actin PCR products in fibroblasts seeded on control and PDT-
treated matrix gels after 6, 12 and 24 h. Data are expressed as median and range. * denotes P%0.03 in controls as compared to
PDT after 24 h. mRNA expression after 6 and 12 h did not show statistical differences.
Modulation of Cell Functions by PDT of Matrix 657Invasive migration is modulated by a variety of
mechanisms and earlier work with bovine cells
showed inhibition of migration, attributed in part to
structural changes of matrix proteins.27 This may be
one important factor in the long-term ability of PDT to
inhibit successfully the occurrence of post-interven-
tional restenosis. Further, PDT of matrix using the
experimental photosensitzer chloroaluminum sulfo-
nated phthalocyanine induced matrix-protein cross-
linking, which resulted in resistance to
metalloproteinase digestion.12
To further elucidate the initial molecular aspects of
the PDT-induced modulation of such cell functions,
key growth factor (TGF-b1, bFGF) mRNA expression
in fibroblasts seeded on PDT-treated and control
collagen matrix gels was quantified within 24 h after
seeding, although mRNA expression does not necess-
arily reflect the cellular production and release of
biologically active growth factors.TGF-b1 has wide-
spread effects on many aspects of growth and
development via interaction with distinct receptors
on the cell surface. TGF-b1 is involved in the vascular
wound healing process mainly by modulating inflam-
mation and extracellular matrix production, thus
playing an important role in the formation of vascular
restenotic lesions.28 The mechanisms of regulation of
this growth factor are extensive and complex.29 Newly
synthesized TGF is released in a latent form and must
be liberated from with its propeptide homodimer
before it can exert its biological actions.28 TGF inhibitsproteases involved in matrix breakdown or matrix
destruction and increases the expression of a number
of matrix-associated structural genes such as collagen
and fibronectin.29 Therefore, it modulates key mech-
anisms of cell migration. The modulation of prolif-
erative processes in cell populations responsible for
the development of restenotic lesions is not fully
understood yet. Although TGF it is a potent inhibitor
of endothelial cell proliferation,30 it can stimulate the
proliferation of fibroblasts.31 Thus, TGF-b is a prom-
ising target for anti-restenosis therapy in humans,
particularly in the long-term inhibition of restenosis
after PDT.
bFGF also has been shown to play an instrumental
role in the complex cascades of events leading to
restenosis.6 The upregulation of bFGF mRNA and
subsequent production of bFGF is a distinct phenom-
enon after arterial injury and has been associated with
an increased migratory and proliferative response of
vascular wall cells.7 Mechanical injury to the vessel
wall results in release of a bFGF like molecule.32 In
addition, experimental treatment with an antibody to
bFGF inhibited proliferation and migration of smooth
muscle cells.26
Previous work showed that PDT-treated bovine
smooth muscle cells had decreased cellular bFGF
levels.33 However, the long-term success of PDT to
inhibit restenosis is highly dependant on the biological
behaviour of untreated, adjacent cell populations,
which have been investigated in this in vitro model.Eur J Vasc Endovasc Surg Vol 28, December 2004
J. Heckenkamp et al.658The present study demonstrated that PDT of collagen
matrix to mimic the cell free vascular matrix after PDT
in vivo significantly decreased TGF-b and bFGFmRNA
levels in fibroblasts not treated by PDT.
This study identified novel effects of PDT treatment
of matrix on human adventitial fibroblast cell func-
tions, including reduction of cell proliferation and
invasive migration. These changes may be modulated
by a reduction of key growth factor mRNA expression
or altered cell–matrix interactions. These newly
identified findings underscore the clinical potential
of PDT to long-term limit the occurrence of restenosis
by favourably modulating adjacent cell populations on
a molecular level. These effects in conjunction with
other know PDT-effects on the vessel wall could all be
major and necessary targets for the observed long-
term PDT-mediated reduction of restenosis. Thus,
because of its multiple favourable effects, PDT is a
unique therapeutic approach of inhibiting restenosis
and provides a strong theoretical basis for its success-
ful clinical application.Acknowledgements
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